BluGlass（BLG）株式概要ブルーグラス・リミテッドはその子会社とともに、オーストラリアと米国で産業、量子、バイオテクノロジー、防衛、ディスプレイ、科学市場向けの半導体製造技術とデバイスを開発している。 詳細BLG ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績0/6財務の健全性5/6配当金0/6リスク分析過去5年間で収益は年間9%減少しました。 過去1年間で株主の希薄化は大幅に進んだ 意味のある収益がありません ( A$6M )Australian市場と比較した過去 3 か月間の株価の変動+1 さらなるリスクすべてのリスクチェックを見るBLG Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueAU$Current PriceAU$0.2776.8% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-15m54m2016201920222025202620282031Revenue AU$53.7mEarnings AU$8.5mAdvancedSet Fair ValueView all narrativesBluGlass Limited 競合他社Archer MaterialsSymbol: ASX:AXEMarket cap: AU$79.0mDA TechnologyLtdSymbol: KOSDAQ:A196490Market cap: ₩36.0bAemulus Holdings BerhadSymbol: KLSE:AEMULUSMarket cap: RM 188.3mAPSSymbol: KOSDAQ:A054620Market cap: ₩86.4b価格と性能株価の高値、安値、推移の概要BluGlass過去の株価現在の株価AU$0.2752週高値AU$0.3852週安値AU$0.16ベータ-0.151ヶ月の変化10.42%3ヶ月変化43.24%1年変化20.45%3年間の変化-69.89%5年間の変化-75.91%IPOからの変化-91.17%最新ニュースBoard Change • May 20No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.New Risk • May 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 9.0% per year over the past 5 years. Shareholders have been substantially diluted in the past year (55% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.9m revenue, or US$4.2m). Market cap is less than US$100m (AU$35.2m market cap, or US$25.5m).Board Change • May 01No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.お知らせ • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct ListingBoard Change • Dec 24No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.お知らせ • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 Australia最新情報をもっと見るRecent updatesBoard Change • May 20No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.New Risk • May 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 9.0% per year over the past 5 years. Shareholders have been substantially diluted in the past year (55% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.9m revenue, or US$4.2m). Market cap is less than US$100m (AU$35.2m market cap, or US$25.5m).Board Change • May 01No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.お知らせ • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct ListingBoard Change • Dec 24No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.お知らせ • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 AustraliaReported Earnings • Aug 28Full year 2025 earnings released: AU$0.006 loss per share (vs AU$0.006 loss in FY 2024)Full year 2025 results: AU$0.006 loss per share (in line with FY 2024). Revenue: AU$5.45m (up 18% from FY 2024). Net loss: AU$11.0m (loss widened 8.3% from FY 2024). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.New Risk • Aug 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 19% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 6.7% per year over the past 5 years. Shareholders have been substantially diluted in the past year (41% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.7m revenue, or US$3.7m). Market cap is less than US$100m (AU$30.9m market cap, or US$20.0m).お知らせ • May 01+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 461,538,462 Price\Range: AUD 0.013 Discount Per Security: AUD 0.00026 Security Features: Attached OptionsBoard Change • Feb 04Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Dec 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Sep 20BluGlass Limited, Annual General Meeting, Oct 21, 2024BluGlass Limited, Annual General Meeting, Oct 21, 2024. Location: at automic group offices, at level 5, 126 phillip street, sydney, nsw 2000. AustraliaReported Earnings • Aug 28Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2023)Full year 2024 results: AU$0.006 loss per share (improved from AU$0.009 loss in FY 2023). Revenue: AU$10.1m (up AU$8.94m from FY 2023). Net loss: AU$10.1m (loss narrowed 14% from FY 2023). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 05BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 157,842,057 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 756,489 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074New Risk • Feb 27New major risk - Revenue and earnings growthEarnings have declined by 4.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.9% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$751k). Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (AU$55.0m market cap, or US$36.0m).お知らせ • Feb 20BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,213 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listingお知らせ • Feb 12+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,216 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listingお知らせ • Jan 10BluGlass Limited Announces Management ChangesBluGlass Limited advised that Ms Elizabeth Spooner has resigned as Company Secretary of the Company. Ms Spooner will be replaced by Robyn Slaughter as Company Secretary with effect from 10 January 2024. Robyn is a Company Secretary who works closely with a number of boards of both listed and unlisted public companies across a range of industries including financial services, biotechnology and healthcare, technology, cyber security and manufacturing. Robyn is a qualified Governance Professional (CGI) and Affiliate of the Governance Institute of Australia (GIA), and holds a Master's degree in Corporate Governance and a Bachelor's degree in Accounting and Finance.New Risk • Oct 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$12m free cash flow). Earnings have declined by 4.9% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$730k). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (AU$81.0m market cap, or US$51.6m).お知らせ • Sep 13Bluglass Limited Announces Executive ChangesBluGlass Limited has appointed Samuel Samhan as Chief Financial Officer on a full-time basis, effective 11 September 2023. Mr. Samhan is a highly credentialled senior executive with more than 20 years financial leadership and commercial operations experience. He was previously the Chief Operating and Financial Officer at Digital Wellness - a global health platform. Other roles include Head of Commercial and Business Transformation at Vitality Works - Sanitarium Workplace Health and Wellness, and Commercial Manager at Evolution Healthcare Group. He replaces part-time CFO Rob Ambrogio, who resigned from the position to pursue personal projects. To ensure a smooth transition, Mr. Ambrogio will remain with the Company until 29 September 2023. Mr. Samhan holds a Bachelor of Business (Accounting), Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.お知らせ • Sep 08BluGlass Limited, Annual General Meeting, Oct 09, 2023BluGlass Limited, Annual General Meeting, Oct 09, 2023, at 10:01 E. Australia Standard Time. Location: Grant Thornton, Level 17, 383 Kent Street Sydney New South Wales Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended 30 June 2023 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider re-election of Directors of the Company; to consider approval of Future Issue of Securities; to consider ratification of Prior Issue of Shares; to consider ratification of Prior Issue of Performance Rights; to consider ratification of Prior Issue of Options; to consider Adoption of Incentive Option & Performance Rights Plan; to consider approval of Issue of Performance Rights to James Walker, Vivek Rao, Stephe Wilks and Jean-Michel Pelaprat Directors of the Company; and to consider approval of Issue of Performance Rights.Reported Earnings • Aug 31Full year 2023 earnings released: AU$0.009 loss per share (vs AU$0.009 loss in FY 2022)Full year 2023 results: AU$0.009 loss per share (in line with FY 2022). Net loss: AU$11.8m (loss widened 26% from FY 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.New Risk • Aug 27New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$12m free cash flow). Earnings have declined by 7.6% per year over the past 5 years. Revenue is less than US$1m (AU$995k revenue, or US$638k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (AU$70.3m market cap, or US$45.1m).Reported Earnings • Feb 25First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.005 loss in 1H 2022)First half 2023 results: AU$0.004 loss per share. Net loss: AU$5.36m (loss widened 16% from 1H 2022).お知らせ • Jan 30BluGlass Limited Launches Laser Product Suite at Photonics WestBluGlass Limited has launched its first suite of gallium nitride (GaN) laser products for customer purchase at leading industry conference, SPIE Photonics West, in San Francisco, USA. BluGlass' lasers are available across 405nm, 420nm, and 450nm wavelengths in both single-mode and multi-modedevices. Customers can inspect performance data and purchase these products in a range of form factors including TO Cans of different sizes and Chip-on-Submounts. BluGlass' suite of available products have passed entry-level commercial specifications following significant product development, optimisation, and performance and reliability testing. The following products are now available for customer purchase: Violet 405nm multi-mode 1W laser; Violet 405nm single-mode 250mW laser; Violet 420nm multi-mode 1W laser; Violet 420nm single-mode 250mW laser; Blue 450nm multi-mode 1W laser; Blue 450nm single-mode 100mW laser. The Company has received interest from customers wanting to deploy BluGlass lasers in their product development programs, which span a multitude of applications including; 3D printing, quantum sensing and computing, material sensing, and flow cytometry. In addition to the launched products, laser diode designs in other wavelengths and specifications are progressing through BluGlass' supply chain, including RPCVD-enhanced products.Reported Earnings • Aug 25Full year 2022 earnings released: AU$0.009 loss per share (vs AU$0.009 loss in FY 2021)Full year 2022 results: AU$0.009 loss per share (vs AU$0.009 loss in FY 2021). Net loss: AU$9.36m (loss widened 49% from FY 2021). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 24First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: AU$0.005 loss per share (vs AU$0.005 loss in 1H 2021). Net loss: AU$4.62m (loss widened 25% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 45% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 26Full year 2021 earnings released: AU$0.009 loss per share (vs AU$0.013 loss in FY 2020)Full year 2021 results: Net loss: AU$6.30m (loss widened 5.1% from FY 2020). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 24First half 2021 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in 1H 2020)First half 2021 results: Net loss: AU$3.69m (loss widened 17% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 36% per year, which means it is performing significantly worse than earnings.株主還元BLGAU SemiconductorAU 市場7D15.2%2.2%0.08%1Y20.5%126.7%3.1%株主還元を見る業界別リターン: BLG過去 1 年間で126.7 % の収益を上げたAustralian Semiconductor業界を下回りました。リターン対市場: BLG過去 1 年間で3.1 % の収益を上げたAustralian市場を上回りました。価格変動Is BLG's price volatile compared to industry and market?BLG volatilityBLG Average Weekly Movement16.0%Semiconductor Industry Average Movement10.0%Market Average Movement10.5%10% most volatile stocks in AU Market17.5%10% least volatile stocks in AU Market4.3%安定した株価: BLGの株価は、 Australian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: BLGの weekly volatility ( 16% ) は過去 1 年間安定していますが、依然としてAustralianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2005n/aJim Hadenbluglass.comブルーグラス・リミテッドはその子会社とともに、オーストラリアと米国で産業、量子、バイオテクノロジー、防衛、ディスプレイ、科学市場向けの半導体製造技術とデバイスを開発している。窒化ガリウム・レーザー・ダイオードを製造する特許取得済みの低温技術であるリモート・プラズマ化学気相成長法を開発・商品化し、ファウンドリーサービスも提供している。同社は2005年に設立され、オーストラリアのシルバーウォーターに本社を置いている。もっと見るBluGlass Limited 基礎のまとめBluGlass の収益と売上を時価総額と比較するとどうか。BLG 基礎統計学時価総額AU$40.77m収益（TTM）-AU$9.36m売上高(TTM)AU$5.86m7.0xP/Sレシオ-4.4xPER（株価収益率BLG は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計BLG 損益計算書（TTM）収益AU$5.86m売上原価AU$2.72m売上総利益AU$3.14mその他の費用AU$12.50m収益-AU$9.36m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.06グロス・マージン53.54%純利益率-159.60%有利子負債／自己資本比率31.7%BLG の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 20:17終値2026/05/22 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BluGlass Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Mark BryanCanaccord Genuity Historic (Wilsons Advisory and Stockbroking Ltd.Darren VincentShaw and Partners Limited
Board Change • May 20No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.
New Risk • May 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 9.0% per year over the past 5 years. Shareholders have been substantially diluted in the past year (55% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.9m revenue, or US$4.2m). Market cap is less than US$100m (AU$35.2m market cap, or US$25.5m).
Board Change • May 01No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.
お知らせ • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
Board Change • Dec 24No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.
お知らせ • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 Australia
Board Change • May 20No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.
New Risk • May 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 9.0% per year over the past 5 years. Shareholders have been substantially diluted in the past year (55% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.9m revenue, or US$4.2m). Market cap is less than US$100m (AU$35.2m market cap, or US$25.5m).
Board Change • May 01No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.
お知らせ • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
Board Change • Dec 24No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.
お知らせ • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 Australia
Reported Earnings • Aug 28Full year 2025 earnings released: AU$0.006 loss per share (vs AU$0.006 loss in FY 2024)Full year 2025 results: AU$0.006 loss per share (in line with FY 2024). Revenue: AU$5.45m (up 18% from FY 2024). Net loss: AU$11.0m (loss widened 8.3% from FY 2024). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.
New Risk • Aug 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 19% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 6.7% per year over the past 5 years. Shareholders have been substantially diluted in the past year (41% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.7m revenue, or US$3.7m). Market cap is less than US$100m (AU$30.9m market cap, or US$20.0m).
お知らせ • May 01+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 461,538,462 Price\Range: AUD 0.013 Discount Per Security: AUD 0.00026 Security Features: Attached Options
Board Change • Feb 04Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Dec 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 20BluGlass Limited, Annual General Meeting, Oct 21, 2024BluGlass Limited, Annual General Meeting, Oct 21, 2024. Location: at automic group offices, at level 5, 126 phillip street, sydney, nsw 2000. Australia
Reported Earnings • Aug 28Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2023)Full year 2024 results: AU$0.006 loss per share (improved from AU$0.009 loss in FY 2023). Revenue: AU$10.1m (up AU$8.94m from FY 2023). Net loss: AU$10.1m (loss narrowed 14% from FY 2023). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 05BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 157,842,057 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 756,489 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074
New Risk • Feb 27New major risk - Revenue and earnings growthEarnings have declined by 4.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.9% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$751k). Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (AU$55.0m market cap, or US$36.0m).
お知らせ • Feb 20BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,213 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing
お知らせ • Feb 12+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,216 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing
お知らせ • Jan 10BluGlass Limited Announces Management ChangesBluGlass Limited advised that Ms Elizabeth Spooner has resigned as Company Secretary of the Company. Ms Spooner will be replaced by Robyn Slaughter as Company Secretary with effect from 10 January 2024. Robyn is a Company Secretary who works closely with a number of boards of both listed and unlisted public companies across a range of industries including financial services, biotechnology and healthcare, technology, cyber security and manufacturing. Robyn is a qualified Governance Professional (CGI) and Affiliate of the Governance Institute of Australia (GIA), and holds a Master's degree in Corporate Governance and a Bachelor's degree in Accounting and Finance.
New Risk • Oct 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$12m free cash flow). Earnings have declined by 4.9% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$730k). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (AU$81.0m market cap, or US$51.6m).
お知らせ • Sep 13Bluglass Limited Announces Executive ChangesBluGlass Limited has appointed Samuel Samhan as Chief Financial Officer on a full-time basis, effective 11 September 2023. Mr. Samhan is a highly credentialled senior executive with more than 20 years financial leadership and commercial operations experience. He was previously the Chief Operating and Financial Officer at Digital Wellness - a global health platform. Other roles include Head of Commercial and Business Transformation at Vitality Works - Sanitarium Workplace Health and Wellness, and Commercial Manager at Evolution Healthcare Group. He replaces part-time CFO Rob Ambrogio, who resigned from the position to pursue personal projects. To ensure a smooth transition, Mr. Ambrogio will remain with the Company until 29 September 2023. Mr. Samhan holds a Bachelor of Business (Accounting), Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.
お知らせ • Sep 08BluGlass Limited, Annual General Meeting, Oct 09, 2023BluGlass Limited, Annual General Meeting, Oct 09, 2023, at 10:01 E. Australia Standard Time. Location: Grant Thornton, Level 17, 383 Kent Street Sydney New South Wales Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended 30 June 2023 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider re-election of Directors of the Company; to consider approval of Future Issue of Securities; to consider ratification of Prior Issue of Shares; to consider ratification of Prior Issue of Performance Rights; to consider ratification of Prior Issue of Options; to consider Adoption of Incentive Option & Performance Rights Plan; to consider approval of Issue of Performance Rights to James Walker, Vivek Rao, Stephe Wilks and Jean-Michel Pelaprat Directors of the Company; and to consider approval of Issue of Performance Rights.
Reported Earnings • Aug 31Full year 2023 earnings released: AU$0.009 loss per share (vs AU$0.009 loss in FY 2022)Full year 2023 results: AU$0.009 loss per share (in line with FY 2022). Net loss: AU$11.8m (loss widened 26% from FY 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.
New Risk • Aug 27New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$12m free cash flow). Earnings have declined by 7.6% per year over the past 5 years. Revenue is less than US$1m (AU$995k revenue, or US$638k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (AU$70.3m market cap, or US$45.1m).
Reported Earnings • Feb 25First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.005 loss in 1H 2022)First half 2023 results: AU$0.004 loss per share. Net loss: AU$5.36m (loss widened 16% from 1H 2022).
お知らせ • Jan 30BluGlass Limited Launches Laser Product Suite at Photonics WestBluGlass Limited has launched its first suite of gallium nitride (GaN) laser products for customer purchase at leading industry conference, SPIE Photonics West, in San Francisco, USA. BluGlass' lasers are available across 405nm, 420nm, and 450nm wavelengths in both single-mode and multi-modedevices. Customers can inspect performance data and purchase these products in a range of form factors including TO Cans of different sizes and Chip-on-Submounts. BluGlass' suite of available products have passed entry-level commercial specifications following significant product development, optimisation, and performance and reliability testing. The following products are now available for customer purchase: Violet 405nm multi-mode 1W laser; Violet 405nm single-mode 250mW laser; Violet 420nm multi-mode 1W laser; Violet 420nm single-mode 250mW laser; Blue 450nm multi-mode 1W laser; Blue 450nm single-mode 100mW laser. The Company has received interest from customers wanting to deploy BluGlass lasers in their product development programs, which span a multitude of applications including; 3D printing, quantum sensing and computing, material sensing, and flow cytometry. In addition to the launched products, laser diode designs in other wavelengths and specifications are progressing through BluGlass' supply chain, including RPCVD-enhanced products.
Reported Earnings • Aug 25Full year 2022 earnings released: AU$0.009 loss per share (vs AU$0.009 loss in FY 2021)Full year 2022 results: AU$0.009 loss per share (vs AU$0.009 loss in FY 2021). Net loss: AU$9.36m (loss widened 49% from FY 2021). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 24First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: AU$0.005 loss per share (vs AU$0.005 loss in 1H 2021). Net loss: AU$4.62m (loss widened 25% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 45% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 26Full year 2021 earnings released: AU$0.009 loss per share (vs AU$0.013 loss in FY 2020)Full year 2021 results: Net loss: AU$6.30m (loss widened 5.1% from FY 2020). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 24First half 2021 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in 1H 2020)First half 2021 results: Net loss: AU$3.69m (loss widened 17% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 36% per year, which means it is performing significantly worse than earnings.
